Dimovski, Aleksandar

Preferred name
Dimovski, Aleksandar
Official Name
Dimovski, Aleksandar

Settings

Now showing 1 - 2 of 2
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Item type:Publication,
    Molecular and cytomorphological characterization of
    <i>Pseudanabaena vesniana</i>
    sp. nov. and
    <i>Pseudanabaena suomiensis</i>
    var.
    <i>macedonica</i>
    var. nov. (Pseudanabaenales, Cyanobacteriota) with evidence of microcystin‐producing
    <i>Pseudanabaena</i>
    taxa
    (Wiley, 2025-08-14)
    Aleksovski, Boris
    ;
    Saraf, Aniket
    ;
    Stefanoska, Evgenija
    ;
    Kiprijanovska, Sanja
    ;
    Vuchurević, Ana
    Detailed molecular and cytomorphological characterization of two toxic Pseudanabaena strains (NMCCC 011 and NMCCC 012), isolated from highly polluted shallow areas of Monospitovo Marsh (North Macedonia), was performed using a “polyphasic” approach. This involved morphological and ultrastructural characterization, phylogenetic assessment of the 16S rRNA gene, analyses of the 16S–23S internal transcribed spacer (ITS) rRNA region, and investigations of the mcyB gene. The 16S rRNA gene phylogenetic analysis and the ITS rRNA region analyses confirmed that strain NMCCC 011 was a novel species for which we have proposed the name Pseudanabaena vesniana sp. nov., whereas NMCCC 012 represented a novel variety of Pseudanabaena suomiensis, here designated as P. suomiensis var. macedonica. The overall 16S rRNA gene phylogenetic analysis grouped Pseudanabaena into four large clades. Two of them comprised the primary lineages of diversification, hosting most Pseudanabaena sensu stricto infrageneric units. Most of these units formed distinctly recognizable subclades corresponding to different Pseudanabaena species (Cyanobacteriota); however, some strains were misidentified, leading to several scattered species through different subclades within the genus. Additionally, the genus Pseudanabaena was determined to be polyphyletic, with some strains clustering within the genera Tumidithrix and Thalassoporum (Cyanobacteriota). The 16S rRNA gene sequence identity within Pseudanabaena sensu stricto ranged from 95.7% to 99.9%, while the identity with Tumidithrix, Thalassoporum, and Thermostichus (Cyanobacteriota) ranged from 87.6% to 92.0%. Furthermore, both strains NMCCC 011 and NMCCC 012 produced microcystins and 2-methylisoborneol. The production of microcystins was confirmed by genetic and enzyme-linked immunosorbent assay (ELISA) analyses. Through this study, we report the presence of the mcyB gene in Pseudanabaena.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Item type:Publication,
    Association Between the Polymorphism of Angiotensin-Converting Enzyme Gene and Interleukin-1 Beta Gene and the Response to Erythropoietin Therapy in Dialysis Patients with Anemia
    (Macedonian Academy of Sciences and Arts/Walter de Gruyter GmbH, 2023-12-01)
    ;
    Eftimovska-Otovikj, N
    ;
    ;
    ;
    Introduction The polymorphism of the angiotensin-converting enzyme (ACE) gene and interleukin-1 beta (IL-1b) gene could be associated with resistance in the treatment of anemia in dialysis patients with recombinant human erythropoietin (rHuEPO). The aim of the study was to evaluate the association between the polymorphism of the ACE and IL-1b genes and the response to rHuEPO therapy in dialysis patients with anemia. Material and methods The study investigated 69 patients on dialysis with anemia treated with recombinant human erythropoietin for 12 months. Genotyping of ACE and IL-1b polymorphism was done in all study patients at the initiation of the study. The patient’s demographic characteristics, dialysis vintage, and laboratory parameters were also evaluated as factors associated with rHuEPO resistance. The erythropoietin resistance index (ERI) was calculated as the weekly rHuEPO dose per kg of body weight, divided by the hemoglobin (Hb) concentration in g/dl. Results The Hb ≥ 110 g/l was registered in 37 (53.6%) patients. Patients with Hb ≥ 110 g/l were characterized by significantly higher serum levels of albumin, cholesterol, and iron than those with Hb < 110 g/l. The serum level of the CRP, the weekly dose of rHuEPO, and ERI were significantly higher in patients with Hb < 110 g/l compared to patients with Hb ≥ 110 g/l. The ERI value of ≥ 10 IUkg/weekly/g/dl was present in 27 (39.1%) patients. The serum levels of ferritin and CRP, and weekly dose of rHuEPO were significantly higher in patients with ERI value ≥ 10 IU kg/weekly/g/dl compared with the patients with ERI value < 10 IUkg/weekly/g/dl. There was no significant association between the ERI and polymorphism of the ACE and IL-1b genes in study patients. Conclusion The polymorphism of the ACE and IL-1b genes was not significantly associated with the response to erythropoietin therapy in dialysis patients with anemia. Iron deficiency, malnutrition, and inflammation were factors associated with anemia and resistance to erythropoietin therapy in dialysis patients.